No results found.
Shawn Kearns, DVM, DACVIM (SAIM), Angell Animal Medical Center, Boston, Massachusetts
Sign in to Print/View PDF
This is a filled error message
To access full articles on www.cliniciansbrief.com, please sign in below.
Create an account for free
Want free access to the #1 publication for diagnostic and treatment information? Create a free account to read full articles and access web-exclusive content on cliniciansbrief.com.
Passwords do not match
Where are you from?
AG|Antigua and Barbuda
BA|Bosnia and Herzegowina
IO|British Indian Ocean Territory
CF|Central African Republic
CC|Cocos (Keeling) Islands
CD|Congo, the Democratic Republic of the
FK|Falkland Islands (Malvinas)
TF|French Southern Territories
HM|Heard and Mc Donald Islands
VA|Holy See (Vatican City State)
IR|Iran (Islamic Republic of)
KR|Korea, Republic of
LY|Libyan Arab Jamahiriya
MK|Macedonia, The Former Yugoslav Republic of
FM|Micronesia, Federated States of
MD|Moldova, Republic of
MP|Northern Mariana Islands
PG|Papua New Guinea
KN|Saint Kitts and Nevis
VC|Saint Vincent and the Grenadines
ST|Sao Tome and Principe
SK|Slovakia (Slovak Republic)
GS|South Georgia and the South Sandwich Islands
PM|St. Pierre and Miquelon
SJ|Svalbard and Jan Mayen Islands
SY|Syrian Arab Republic
TZ|Tanzania, United Republic of
TT|Trinidad and Tobago
TC|Turks and Caicos Islands
AE|United Arab Emirates
UM|United States Minor Outlying Islands
VG|Virgin Islands (British)
VI|Virgin Islands (U.S.)
WF|Wallis and Futuna Islands
DC|District of Columbia
Micronesia (Federated States Of)
US Minor Outlying Islands
Armed Forces Africa
Armed Forces Americas Aa (except Canada)
Armed Forces Canada
Armed Forces Europe Ae
Armed Forces Middle East Ae
Armed Forces Pacific Ap
PE|Prince Edward Island
Tell us about yourself
Choose the category that describes your business/professional activity
What best describes your position? (question 1 of 2)
Veterinarian Role: (question 2 of 2)
Non-Veterinarian Role: (question 2 of 2)
Yes, I would like to receive updates about products & services, promotions, special offers, news & events from Brief Media.
Already have an account? Sign in here.
Acceptance to the GDPR regulations is required.
This retrospective study examined records of a cohort of dogs with presumed primary immune-mediated neutropenia. Included in the study were 35 dogs with neutrophil concentrations <1.5 × 109 cells/L (based on a minimum of 2 CBCs) and for which other causes of neutropenia or secondary immune-mediated neutropenia were excluded. The authors sought to describe presenting clinical characteristics, CBC results, bone marrow characteristics, therapies used, clinical response to treatment, and outcomes at 6 months and one year.
The most common presenting clinical complaints included lethargy and anorexia (63%); 46% of dogs had increased body temperature. Neutropenia was <0.5 × 109 cells/L in 60% of dogs; 8 had thrombocytopenia, which was severe in 3 dogs. Twenty-three dogs had myeloid hyperplasia, 10 had myeloid hypoplasia, and 2 had normal myelopoiesis. Serum chemistry results included elevated liver values and various electrolyte abnormalities. Abdominal ultrasonographic images and thoracic and abdominal radiographs were unremarkable in most cases; splenomegaly was the most common finding. Dogs were started on a corticosteroid initially; 43% required adjunctive treatment using either azathioprine or cyclosporine. Neutropenia resolved in 32 of 33 dogs within 2 weeks of beginning treatment and in all dogs within 1 month.
Although response rates for resolution of neutropenia were rapid in this report, other cytopenias may take longer to resolve or may require additional treatment. In addition, relapse was common in this study (34.3%), emphasizing the need for consistent patient follow-up and the need for further studies to determine optimal therapy—in particular, steroid doses, treatment duration, and secondary immunosuppressive drugs.
A diagnosis of immune-mediated neutropenia remains a diagnosis of exclusion. Because it is considered an uncommon cause of neutropenia,1-3 testing to exclude other causes should include urine culture, abdominal ultrasonography, thoracic radiography, and vector-borne disease testing. Other infectious disease (eg, fungal, parvovirus) testing may be warranted depending on the patient’s geographic location, age, and vaccination status. In one retrospective evaluation of neutropenia, nonbacterial infectious diseases were found most commonly.4
Article continues after advertisement
Key pearls to put into practice:
Because immune-mediated neutropenia remains primarily a diagnosis of exclusion, ancillary testing is important to exclude other causes of neutropenia.
Although the initial response to treatment appears favorable and fast, owners should be educated about the need for follow-up due to potential relapse during drug tapering or treatment cessation.
Although the ideal secondary immunosuppressive drug remains unknown, additional therapies beyond glucocorticoids can be considered to maintain remission.
Material from Clinician’s Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*
*2007-2017 PERQ and Essential Media Studies
It's Free & Simple
Delivered to Your Inbox
Join the Conversation
Follow us @CliniciansBrief
© 2018 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved.